LOBELL J JAY
SEC CIK 1172659 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FBIO | Fortress Biotech, Inc. | Dir | 192.4K | $251.5K | — | 6 | 2022-01-01 | 2026-01-01 |
Most active insiders at FBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Jin David | CFO | — | — |
| 2 | Lorenz Kevin | Dir | — | — |
| 3 | Klein Dov | Dir | — | — |
| 4 | Harvey Jimmie | Dir | — | — |
| 5 | Hoenlein Malcolm | Dir | — | — |
| 6 | LOBELL J JAY | Dir | — | — |
| 7 | WEISS MICHAEL S | Executive Vice COB, Dir | — | — |
| 8 | ROSENWALD LINDSAY A MD | Pres, CEO, COB, Dir, 10% | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2026-01-01 | FBIO | Fortress Biotech, Inc. | LOBELL J JAY | Dir | A - Grant | $0.00 | +27.3K | 192.4K | +17% | $0 | |
| 2025-01-03 | 2025-01-01 | FBIO | Fortress Biotech, Inc. | LOBELL J JAY | Dir | A - Grant | $0.00 | +49.4K | 165.1K | +43% | $0 | |
| 2024-01-03 | 2024-01-01 | FBIO | Fortress Biotech, Inc. | LOBELL J JAY | Dir | A - Grant | $0.00 | +6,666 | 115.7K | +6% | $0 | |
| 2023-02-14 | 2023-02-10 | FBIO | Fortress Biotech, Inc. | LOBELL J JAY | Dir | P - Purchase | $0.84 | +299.4K | 1.64M | +22% | +$251.5K | |
| 2023-01-04 | 2023-01-01 | FBIO | Fortress Biotech, Inc. | LOBELL J JAY | Dir | A - Grant | $0.00 | +100.0K | 1.34M | +8% | $0 | |
| 2022-04-29 | 2022-01-01 | FBIO | Fortress Biotech, Inc. | LOBELL J JAY | Dir | A - Grant | $0.00 | +100.0K | 1.24M | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations